Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy-Reference-Cited by-同舟云学术

Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy

Published:2018-04-05 Issue:5 Volume:38 Page:1099-1106
ISSN:0272-4340
Container-title:Cellular and Molecular Neurobiology
language:en
Short-container-title:Cell Mol Neurobiol

Author:

Jawed Irfan,Velarde Margarita,Därr Roland,Wolf Katherine I.,Adams Karen,Venkatesan Aradhana M.,Balasubramaniam Sanjeeve,Poruchynsky Marianne S.,Reynolds James C.,Pacak Karel,Fojo Tito

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,General Medicine

Link

http://link.springer.com/article/10.1007/s10571-018-0579-4/fulltext.html

Reference42 articles.

1. Agarwal G, Sadacharan D, Kappor A et al (2011) Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective case-control study. Surgery 150:1202–1211

2. Amar L, Bertherat J, Baudin E et al (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23:8812–8818

3. Andersen GS, Toftdahl DB, Lund JO et al (1988) The incidence rate of phaeochromocytoma and Conn’s syndrome in Denmark, 1977–1981. J Hum Hypertens 2:187–189

4. Averbuch SD, Steakley CS, Young RC et al (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 109:267–273

5. Bausch B, Wellner U, Bausch D et al (2014) Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21:17–25

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents;Nature Reviews Endocrinology;2024-08-15

2. Management of metastatic pheochromocytomas and paragangliomas: when and what;Current Problems in Cancer;2024-08

3. Tumor metabolism in pheochromocytomas: clinical and therapeutic implications;Exploration of Targeted Anti-tumor Therapy;2024-04-24

4. Anlotinib for Metastatic Progressed Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data;Journal of the Endocrine Society;2024-04-02

5. The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives;Pharmaceuticals;2024-03-08